DeCS

Descriptor English:

Selegiline

Descriptor Spanish:

Selegilina

Spanish from Spain

Descriptor	selegilina
Entry term(s)	deprenal deprenalina
Scope note:	Inhibidor selectivo e irreversible de la monoaminooxidasa tipo B que se utiliza para el tratamiento de pacientes con ENFERMEDAD DE PARKINSON recién diagnosticada y para el tratamiento de trastornos depresivos. El compuesto sin designación isomérica es el deprenilo.

Descriptor Portuguese:

Selegilina

Descriptor French:

Sélégiline

Tree number(s):

D02.092.471.683.915

RDF Unique Identifier:

https://id.nlm.nih.gov/mesh/D012642

Scope note:

A selective, irreversible inhibitor of Type B monoamine oxidase that is used for the treatment of newly diagnosed patients with PARKINSON DISEASE, and for the treatment of depressive disorders. The compound without isomeric designation is Deprenyl.

Allowable Qualifiers:

AA analogues et dérivés
AD administration et posologie
AE effets indésirables
AG agonistes
AI antagonistes et inhibiteurs
AN analyse
BL sang
CF liquide cérébrospinal
CH composition chimique
CL classification
CS synthèse chimique
EC économie
HI histoire
IM immunologie
IP isolement et purification
ME métabolisme
PD pharmacologie
PK pharmacocinétique
PO intoxication
RE effets des radiations
SD ressources et distribution
ST normes
TO toxicité
TU usage thérapeutique
UR urine

Pharm Action:

Antidepressive Agents
Antiparkinson Agents
Monoamine Oxidase Inhibitors
Neuroprotective Agents

Registry Number:

2K1V7GP655

CAS Type 1 Name:

Benzeneethanamine, N,alpha-dimethyl-N-2-propynyl-, (R)-

DeCS ID:

22667

Unique ID:

D012642

Documents indexed in the Virtual Health Library (VHL):

Click here to access the VHL documents